This inventor holds 2 USPTO granted patents. Top assignee: Eli Lilly and Company. Active years: 1997-1998.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1997-1998
Title: Innovator Spotlight: Fred M. Perry of Eli Lilly and Company
Introduction: Fred M. Perry is an accomplished inventor based in West Lafayette, Indiana, known for his contributions to the field of pharmaceutical intermediates. With a total of two patents to his name, his work significantly enhances the development of vital chemical compounds.
Latest Patents: Fred M. Perry's latest patents focus on the innovative processes for preparing benzoic acid derivative intermediates. The first patent outlines novel methods for producing compounds characterized by specific formulae, detailing the versatility of R¹ and R² groups, which can be independently chosen from various alkyl chains or combined to form complex structures such as piperidinyl and morpholino. His contributions in this area reflect a deep understanding of organic chemistry and the potential applications of his inventions in pharmaceuticals.
Career Highlights: Throughout his career, Fred M. Perry has established himself as a key figure in the research and development teams at Eli Lilly and Company. His expertise has driven forward various projects aimed at creating more effective medicinal compounds, underlining his commitment to innovation in the pharmaceutical field.
Collaborations: In his role at Eli Lilly and Company, Fred has collaborated with experts such as Douglas P. Kjell. These partnerships have facilitated the exchange of ideas and expertise, leading to advancements in drug development and the refinement of chemical processes.
Conclusion: Fred M. Perry stands out as a notable inventor whose work has had a lasting impact on the pharmaceutical industry. His latest patents demonstrate a commitment to innovation and a profound understanding of chemical processes, ensuring that his contributions will continue to benefit researchers and patients alike. Through his collaboration with talented colleagues, Perry exemplifies the spirit of teamwork in scientific discovery.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
